Cue Biopharma, Inc. - Common Stock, par value $0.001 per share (CUE)

Historical Holders from Q1 2018 to Q1 2025

Symbol
CUE on Nasdaq
CUSIP
22978P106
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
61.3M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
11.8M
Holdings value
$12.8M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
55
Number of buys
27
Number of sells
-13
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Cue Biopharma, Inc. - Common Stock, par value $0.001 per share (CUE)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Bleichroeder LP 9.99% $5.94M 6.13M Bleichroeder LP Mar 19, 2025
Slate Path Capital LP 1.4% $891K 919K Slate Path Capital LP Dec 31, 2024

Institutional Holders of Cue Biopharma, Inc. - Common Stock, par value $0.001 per share (CUE)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 498K $453K -$436K $0.91 4
2024 Q4 11.8M $12.8M -$1.53M $1.09 55
2024 Q3 13.9M $10.5M -$289K $0.76 51
2024 Q2 13.8M $17.1M -$3.74M $1.24 71
2024 Q1 16.4M $31M +$2.74M $1.89 74
2023 Q4 14.9M $39.3M +$2.43M $2.64 79
2023 Q3 14M $32.1M -$653K $2.30 74
2023 Q2 13.8M $50.5M +$6.69M $3.65 77
2023 Q1 12.1M $43M -$2.54M $3.57 62
2022 Q4 12.8M $36.4M +$90.3K $2.85 60
2022 Q3 12.8M $28.6M -$2.98M $2.23 59
2022 Q2 13.6M $33.9M -$11.5M $2.49 66
2022 Q1 17.8M $86.8M +$4.6M $4.88 94
2021 Q4 16.5M $187M -$11.2M $11.31 85
2021 Q3 16.8M $244M -$25.1M $14.57 85
2021 Q2 18.2M $211M -$4.07M $11.65 88
2021 Q1 18.8M $229M -$7.72M $12.20 85
2020 Q4 17.9M $223M -$3.84M $12.51 91
2020 Q3 19.5M $294M +$50M $15.05 89
2020 Q2 16M $393M +$85.1M $24.51 99
2020 Q1 12.1M $171M +$36M $14.19 69
2019 Q4 10.6M $168M +$63.1M $15.88 60
2019 Q3 6.07M $51.2M +$13.4M $8.43 42
2019 Q2 4.47M $40.1M +$9.96M $8.99 34
2019 Q1 3.44M $26.6M +$1.87M $7.73 36
2018 Q4 3.21M $15.1M -$2.09M $4.70 33
2018 Q3 3.58M $32.4M +$3.24M $9.05 36
2018 Q2 3.14M $37.3M +$15.4M $11.86 34
2018 Q1 1.79M $25.1M +$25.1M $14.05 26